Диссертация (1140116), страница 36
Текст из файла (страница 36)
Power, J.V. Tingle, R.I. Reid[et al.] // JAHA. - 2017. – Vol. 6. – P. e005608.154.Longitudinal systolic blood pressure characteristics and integrity of white matter tractsin a cohort of very old black and white adults / C. Rosano, K.Z. Abebe, H.J. Aizenstein [et al.] /American Journal of Hypertension. – 2015. – Vol. 28, N 3. – P. 326–334.155.Interindividual variation in blood pressure is associated with regional white matterintegrity in generally healthy older adults / D.H. Salat, V.J. Williams, E.C. Leritz [et.
al.] /Neuroimage. – 2012. – Vol. 59, N. 1. – P. 181–192.156.Effects of systolic blood pressure on white-matter integrity in young adults in theFramingham Heart Study: a cross-sectional study / P. Maillard, S. Seshadri, A. Beiser [et al.] //Lancet Neurology. – 2012. – Vol. 11, N 12. – P. 1039–1047.157. Multiple indicators of age-related differences in cerebral white matter and the modifying effectsof hypertension / S.
Burgmans, M.P.J. van Boxtel, E.H. Gronenschild [et al.] / Neuroimage. –2010. – Vol. 49, N 3, P. 2083.158. Kennedya, K.M. Pattern of normal age-related regional differences in white mattermicrostructure is modified by vascular risk / K.M. Kennedya, N. Raz // Brain Research. – 2009. –Vol. 1297. – P. 41–56.159. Characterization of white matter damage in ischaemic leukoaraiosis with diffusion tensor MRI /D. Jones, D.
Lythgoe, M. Horsfield [et al.] // Stroke. – 1999. – Vol. 30. – P. 393–397.153160. Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo studywith diffusion tensor MRI / H. Chabriat, S. Pappata, C. Poupon [et al.] // Stroke. – 1999. –Vol.
30. – P. 2637–2643.161. Diffusion tensor imaging and MR spectroscopy in hypertension and presumed cerebral smallvessel disease / A. Nitkunan, R.A. Charlton, D.J. McIntyre [et al.] / Magnetic Resonance inMedicine. – 2008. – Vol. 59, N 3. – P. 528-534.162. CARDIA: study design, recruitment, and some characteristics of the examined subjects / G.D.Friedman, G.R. Cutter, R.P. Donahue [et al.] // Journal of Clinical Epidemiology. – 1988. – Vol.41, N 11. - P. 1105-1116.163. Hypertension-related alterations in white matter microstructure detectable in middle age / L.
K.McEvoy, C. Fennema-Notestine, L. T. Eyler [et al.] // Hypertension. – 2015. – Vol. 66. - P. 317323.164. Sierra, C. White matter lesions and cognitive impairment as silent cerebral disease inhypertension / C. Sierra, A. Coca // The scientific world journal. – 2006. – Vol. 6. – P. 494–501.165. Спиновое маркирование артериальной крови (ASL) — метод визуализации и оценкимозгового кровотока / И.Н. Пронин, Л.М. Фадеева, А. Е.
Подопригора [и др.] // Лучеваядиагностика и терапия. – 2012. – Т. 3, № 3. – С. 64-78.166. Reduced perfusion in normal-appearing white matter in mild to moderate hypertension asrevealed by 3D pseudocontinuous arterial spin labeling / T. Wang, Y. Li, X. Guo [et al.] //Journal of Magnetic Resonance Imaging. – 2016. – Vol. 43, N 3. – P.
635-643.167. White matter hyperintensity volume and cerebral perfusion in older individuals withhypertension using arterial spin-labeling / J.W. van Dalen, H.J. Mutsaerts, A.J. Nederveen [et al.]// American Journal of Neuroradiology. – 2016. – V. 37. – P. 1824–1830.168. Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matterhyperintensities / A.J.
Bastos-Leite, J.P.A. Kuijer, S.A.R.B. Rombouts [et al.] // AmericanJournal of Neuroradiology. – 2008. – Vol. 29. – P. 1296–1301.169. Abnormal regional cerebral blood flow in cognitively normal elderly subjects withhypertension / W. Dai, O. L.
Lopez, O. T. Carmichael [et al.] // Stroke. – 2008. – Vol. 39. – P.349–354.170. Intensive blood pressure lowering increases cerebral blood flow in older subjects withhypertension / D. Tryambake, J. He, M.J. Firbank [et al.] // Hypertension. – 2013. – Vol. 61. – P.1309–1315.171. The International Classification of Headache Disorders, 3rd edition // Cephalalgia. – 2018. Vol. 38, N 1. – P.
1–211.154172. Janeway, T.C. A clinical study of hypertensive cardiovascular disease / T.C. Janeway //Archives of Internal Medicine. – 1913. – Vol. 12. – P. 755–798.173. Elevated blood pressure and headache disorders in China – associations, under-treatment andimplications for public health / M. He, M. Yu, R. Liu [et al.] // The Journal of Headache andPain. – 2015. – Vol. 16.
– P. 86.174. Headache in patients with mild to moderate hypertension is generally not associated withsimultaneous blood pressure elevation / P. Kruszewski, L. Bieniaszewski, J. Neubauer [et al.] //Journal of Hypertension. – 2000. – Vol. 18. – P. 437—444.175. Headache is not more frequent among patients with moderate to severe hypertension / F.D.Fuchs, M.
Gus, L.B. Moreira [et al.] // Journal of Human Hypertension. – 2003. – Vol. 17. – P.787—789.176. Яхно, Н.Н. Головная боль: руководство для врачей / Н.Н. Яхно, В.А. Парфенов, В.В.Алексеев. – М.: Ремедиум, 2000. - 75 с.177. Law, M. R. Calcium channel blockers and headache / M. R.
Law, J. K. Morris, N. J. Wald //British Journal of Clinical Pharmacology. – 2006. – Vol. 63, N 2. – P. 157–158.178. Головная боль у больных артериальной гипертонией / В.А. Парфенов, В.В. Алексеев,Н.С. Шварева [и др.] // Клиническая геронтология. – 2001. – Т. 6, № 5. – С. 3-9.179. Парфенов В.А. Ведение пациентов с дисциркуляторной энцефалопатией в амбулаторнойпрактике / В.А. Парфенов, Д.В. Неверовский // Неврология, нейропсихиатрия,психосоматика. – 2015.
– Т. 7, № 1. – С. 37–42.180. Weiss, N.S. Relation of high blood pressure to headache, epistaxis, and selected othersymptoms. The United States Health Examination Survey of Adults / N.S. Weiss // New EnglandJournal of Medicine. – 1972. - Vol. 287. – P. 190–194.181. Migraine is more frequent in individuals with optimal and normal blood pressure: a populationbased study / M.
Wiehe, S.C. Fuchs, L.B. Moreira [et al.] // Journal of Hypertension. – 2002. –Vol. 20, N 7. – P. 1303-1306.182. Мигрень и артериальная гипертензия / Г.Р. Табеева, А.В. Муранова, Е.Н. Кострыгина [идр.] // Неврология, нейропсихиатрия, психосоматика. – 2015. – T. 7, № 4. – C. 4–10.183. Hypertension and migraine comorbidity: prevalence and risk of cerebrovascular events:evidence from a large, multicenter, crosssectional survey in Italy (MIRACLES study) / G.Mancia, E.A.
Rosei, E. Ambrosioni [et al.] // Journal of Hypertension. – 2011. – Vol. 29. – P.309–318.184. Hypertension and migraine in the northern Manhattan study / H. Gardener, T.Monteith, T.Rundek [et al.] // Ethnicity & Disease. – 2016. – Vol. 26, N 3. – P. 323-330.155185.
The insula: A “Hub of Activity” in migraine / D. Borsook, R. Veggeberg, N. Erpelding [et al.]// Neuroscientist. – 2016. – Vol. 22, N 6. – P. 632–652.186. Efficacy of lisinopril in migraine prophylaxis – an open label study / S. Schuh-Hofera, U.Flachb, A. Meiselb [et al.] // European Journal of Neurology. – 2007. – Vol. 14.
– P. 701–703.187. Charles,J.A.Preventionofmigrainewitholmesartaninpatientswithhypertension/prehypertension / J. A. Charles, S. Jotkowitz, L. H. Byrd // Headache. – 2006. –Vol. 46. – P. 503-507.188. Telmisartan in migraine prophylaxis: a randomized, placebo-controlled trial / H.C. Diener, A.Gendolla, A. Feuersenger [et al.] // Cephalalgia. – 2009. – Vol. 29.
– P. 921–927.189. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomizedcontrolled trial / E. Tronvik, L.J. Stovner, G. Helde [et al.] // JAMA. – 2003. – Vol. 289, N 1. –P. 65-69.190. Frediani, F. Peripheral mechanism of action of antimigraine prophylactic drugs / F. Frediani,V. Villani, G. Casucci // Neurological Sciences. – 2008. – Vol. 29. – P. S127–S130.191. Butt, J.H. Endothelial function in migraine with aura – a systematic review / J.H.
Butt, U.Franzmann, C. Kruuse // Headache. – 2015. – Vol. 55, N 1. – P. 35-54.192. Кисляк, О. А. Лечение артериальной гипертензии и профилактика сердечно-сосудистыхзаболеваний у женщины репродуктивного возраста с мигренью / О. А. Кисляк, А. В.Стародубова, Ю. Б. Червякова // Медицинский совет. – 2017. - №12. – C. 26-32.193. Яхно,Н.Н.Мигрень/Н.Н.Яхно,Г.Р.Табеева.-М.:ГЭОТАР-Медиа, 2011. – 624 с.194.
Толмачева,ВА.Причиныголовокружения/В.А.Толмачева//Неврология,нейропсихиатрия, психосоматика. – 2010. – Т 2, № 4. – С. 18-23.195. Vertigo/dizziness as a drugs’ adverse reaction / S. Chimirri, R. Aiello, C. Mazzitello [et al.] //Journal of Pharmacology & Pharmacotherapeutics. – 2013. – Vol. 4 (Suppl.
1). – P. S104–S109.196. Neuhauser, H.K. Vertigo: epidemiologic aspects / H.K. Neuhauser, T. Lempert // Seminars inNeurology. – 2009. – Vol. 29, N 5. – P. 473–481.197. Burden of dizziness and vertigo in the community / H. K. Neuhauser, A. Radtke, M. vonBrevern [et al.] // Archives of Internal Medicine. – 2008. – Vol. 168, N 19. – P. 2118-2124.198. The epidemiology of vertigo, dizziness, and unsteadiness and its links to co-morbidities / A.Bisdorff, G. Bosser, R. Gueguen [et al.] // Frontiers in Neurology. – 2013.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
